BBOTVSLEXX• 12 Months (Normalized)
BBOT vs LEXX (BridgeBio Oncology Therapeutics Inc. vs Lexaria Bioscience Corp.)
Showing Closing Date Range from Oct 2, 2025 to Oct 2, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.89
-68.73%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
LEXX Performance $2.88
-78.43%
Lexaria Bioscience Corp.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+9.7 pts
BBOT outperforming by 9.70 percentage points
BBOTLEXX
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT LEXX
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(251 dates)
| Date | BBOT Price | BBOT Gain (%) | LEXX Price | LEXX Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 02, 2026 | $3.89 | -68.73% | $2.88 | -78.43% | +9.70% |
| Sep 30, 2026 | $4.10 | -67.04% | $3.15 | -76.40% | +9.36% |
| Sep 29, 2026 | $3.92 | -68.49% | $3.13 | -76.55% | +8.06% |
| Sep 28, 2026 | $3.81 | -69.37% | $3.23 | -75.84% | +6.47% |
| Sep 25, 2026 | $3.95 | -68.25% | $3.28 | -75.43% | +7.18% |
| Sep 24, 2026 | $3.99 | -67.93% | $3.37 | -74.76% | +6.83% |
| Sep 23, 2026 | $4.16 | -66.56% | $3.24 | -75.77% | +9.21% |
| Sep 22, 2026 | $4.66 | -62.54% | $- | - | |
| Sep 21, 2026 | $4.66 | -62.54% | $3.43 | -74.34% | +11.80% |
| Sep 18, 2026 | $4.77 | -61.66% | $3.24 | -75.73% | +14.07% |
| Sep 17, 2026 | $4.89 | -60.69% | $3.29 | -75.36% | +14.67% |
| Sep 16, 2026 | $4.76 | -61.74% | $3.10 | -76.82% | +15.08% |
| Sep 15, 2026 | $4.88 | -60.77% | $3.21 | -75.96% | +15.19% |
| Sep 14, 2026 | $5.05 | -59.41% | $3.55 | -73.41% | +14.00% |
| Sep 11, 2026 | $4.95 | -60.21% | $3.97 | -70.26% | +10.05% |
Page 1 of 17